Skip to main content
. 2022 Apr 28;15(5):545. doi: 10.3390/ph15050545

Figure 5.

Figure 5

Number of in vitro and in vivo studies (A); type of animals (B) and specific models (C) used for the pharmacological evaluation of multitarget anti-AD compounds in the period 1990–2020.